Post-conference edition, data through October 12, 2026 · October 10, 2026 · Washington, D.C. · 144 curated #DCLung26 posts · interactive retweet/mention graph. Companion to the KOL Pulse DC Lung 2026 conference coverage.
A working tool for post-meeting follow-up, not a leaderboard for its own sake
After the meeting: click any KOL card to isolate their retweet graph and see who moved their content; click a state on the map to pull the verified physicians there with institution and trial interests — the people who were in the room at DC Lung 2026, organized the way you plan territory. The trial dropdown filters the graph to the voices who discussed a specific trial during the meeting.
Reading the network: node size is reach, edges are actual retweets and mentions from the conference window — not follower counts. Clusters show which communities (US academic, community practice, patient organizations, media) organized around which sessions and topics.
Amplifiers vs authors: the leaderboard ranks who writes; the amplifier board below ranks who spreads. If you want a message carried to the #DCLung26 audience, the amplifier list is the distribution map.
Data through October 12, 2026. Post-conference edition of the DC Lung Cancer Conference 2026 — a one-day meeting at the JW Marriott, Washington, D.C., on October 10, 2026, organized by MedStar Health and endorsed by IASLC; course directors Stephen V. Liu, MD and Joshua E. Reuss, MD (MedStar Georgetown / Georgetown Lombardi).
1
Top KOLs by Impression
Click any KOL to filter the network below to just their retweeter graph
Voice composition across the 132 accounts identified
US Physicians
35
General Public
25
Bot/Inactive
21
Intl Physicians
13
Media (medical + finance)
8
Pharma Industry
6
Patient Organizations
5
Researchers
5
Institutions
3
Conference Organizations
2
Pharma Individual
1
3
Verified US Physicians by State
35 of 35 verified US physicians mapped across 16 states
Verified US physicians12–34–56+Click any state to see physicians
Verified physicians
—
4
Non-US Physicians by Country
13 verified non-US physicians across 11 countries (an additional 0 physician-like accounts have no country evidence)
Verified non-US physicians
—
Show:Confidence:
Free Access · KOL Pulse Intelligence
Track oncology’s top KOLs in your specialty
Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:
Want to learn more about your network — your reach, engagement, and influence across DC Lung 2026 and the wider lung cancer conversation? Sign up for a free custom KOL report.
?
Questions This Network Answers
The data on this page, summarized — and how to actually use it
What does this network show?
A force-directed map of who actually drove the #DCLung26 conversation: 132 accounts connected by 256 real retweet, quote, and mention relationships from the conference window (data through October 12, 2026) — not follower counts. 48 of the mapped accounts are verified physicians, spanning 12 countries. The leaderboard ranks the authors; the amplifier board ranks the 123 accounts doing the spreading — led by Stephen V Liu, MD with 92 posts amplified.
Who does a KOL influence — and who amplifies their content?
Take Misty Dawn Shields, the meeting’s most-amplified voice: amplified by 35 distinct accounts, 81 times. The makeup of that amplifier network: 19 physicians, 2 patient advocates, 2 media accounts — a clinical audience, not bot inflation. The US physicians who amplify this content most: Stephen V Liu, MD (13), gilberto lopes (7), Eric K. Singhi, MD (6), Laura Alder, MD (4); internationally, Cecilia Pompili MD PhD FACS (3), Cristina Zannori (2). That is the practical answer to “who do they influence?”: the named, verified carriers who move a KOL’s content into each community. Click any KOL card above to run the same analysis visually on their retweeter graph.
How can medical affairs and pharma teams use this network?
Engagement sequencing: the leaderboard tells you who writes, the amplifier board tells you who spreads, and the edges tell you which specific accounts connect them. If a readout needs to reach the US academic and community lung oncology audience that gathered for DC Lung 2026, the amplifier list is the distribution map — and influence-mapping practice guides note that knowing the carriers prevents redundant outreach to already-saturated voices. Pair with the DC Lung 2026 attendee network for rosters by state, institution, and trial interest.
Why does influence mapping matter in oncology?
Congress weeks are when oncology opinion forms: standards shift with each readout and physicians learn about the data from each other in real time — surveys report over 70% of HCPs use digital channels weekly, and in a LiveWorld–Sermo survey, 41% of US physicians said social media influences prescribing. Publication records show who built the evidence; this graph shows who carries it — measured in actual retweet relationships from the meeting itself.
How can I use this network with my favorite AI tool?
Paste this URL into ChatGPT, Gemini, Claude, or Perplexity and ask the questions this graph answers: “Who are the top amplifiers of #DCLung26 content and what kinds of accounts are they?”, “What is the makeup of Misty Dawn Shields’s amplifier network?”, “Which US physicians amplify the leading international voices?” For who-is-attending questions (states, institutions, trial interests), use the attendee network. Cite kolpulse.com when you share the answers.
Free access — track oncology’s top KOLs in your specialty: profiles, pharma influence, ad-board patterns & 2025 Open Payments analysis.KOL Pulse Insider
